[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@occams_tooth Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1858315561790545920.png) @occams_tooth Occam's Toothbrush

Occam's Toothbrush posts on X about $arwr, $beam, $ptct, $rna the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1858315561790545920/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1858315561790545920/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXX -XX%
- X Months XXXXXXX +310%
- X Year XXXXXXX +29,893%

### Mentions: X [#](/creator/twitter::1858315561790545920/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1858315561790545920/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XX%
- X Months XXX +69%
- X Year XXX +4,200%

### Followers: XXX [#](/creator/twitter::1858315561790545920/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1858315561790545920/c:line/m:followers.svg)

- X Week XXX +2.70%
- X Month XXX +8.30%
- X Months XXX +466%
- X Year XXX +2,365%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1858315561790545920/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1858315561790545920/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  XXXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[$arwr](/topic/$arwr) 15.38%, [$beam](/topic/$beam) 15.38%, [$ptct](/topic/$ptct) 15.38%, [$rna](/topic/$rna) 15.38%, [rna](/topic/rna) 15.38%, [$ions](/topic/$ions) 7.69%, [$150m](/topic/$150m) 7.69%, [$pfe](/topic/$pfe) 7.69%, [target](/topic/target) 7.69%, [$100mtarget](/topic/$100mtarget) XXXX%

**Top accounts mentioned or mentioned by**
[@semodough](/creator/undefined) [@geneinvesting](/creator/undefined) [@seedy19tron](/creator/undefined) [@kms_ghostt](/creator/undefined)

**Top assets mentioned**
[Arrowhead Research Corporation (ARWR)](/topic/$arwr) [BEAM (BEAM)](/topic/$beam) [PTC Therapeutics, Inc. (PTCT)](/topic/$ptct) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Pfizer, Inc. (PFE)](/topic/$pfe) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Denali Therapeutics Inc. Common Stock (DNLI)](/topic/$dnli) [Royalty Pharma plc Class A Ordinary Shares (RPRX)](/topic/$rprx) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) [Novartis AG (NVS)](/topic/$nvs) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Cidara Therapeutics, Inc. (CDTX)](/topic/$cdtx) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Roivant Sciences Ltd. Common Shares (ROIV)](/topic/$roiv) [Insmed, Inc. (INSM)](/topic/$insm) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Krystal Biotech, Inc. Common Stock (KRYS)](/topic/$krys) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny)
### Top Social Posts
Top posts by engagements in the last XX hours

"Arrowhead $ARWR stock move is logical but timing is puzzling. APOC3 program seems better than Ionis $IONS and catalyst rich 2026 on the horizon (sHTG obesity CNS etc). But all of this was already known so why is the stock up XX% today"  
[X Link](https://x.com/occams_tooth/status/1993781016897450043)  2025-11-26T20:36Z XXX followers, XXX engagements


"$150M UF for XX% co-co on a single target. The new high watermark for preclinical genetic medicine deals I think $BEAM $PFE at $100M/target was previous record holder $REGN"  
[X Link](https://x.com/occams_tooth/status/1995521002928062923)  2025-12-01T15:50Z XXX followers, XXX engagements


"I have never understood how PTCs small molecule splicing modulators can be specific for ONE snRNP at ONE exon in ONE gene in the entire genome. Seems very non-intuitive to me. Source: $PTCT R&D day"  
[X Link](https://x.com/occams_tooth/status/1996039189583069296)  2025-12-03T02:10Z XXX followers, XXX engagements


"$DNLI $RPRX is a good deal: X. $RPRX values tivi above street. $275M for X% royalty; assuming XX% margins tivi is worth $2B X. $DNLI up 7%. Good example for naysayers who say no such thing as non-dilutive financing. Thats true in theory but not for undervalued assets"  
[X Link](https://x.com/occams_tooth/status/1996937319618957713)  2025-12-05T13:38Z XXX followers, XXX engagements


"@GeneInvesting Great data and agree it seems differentiated vs $CRSP on X. Better efficacy (100% VOC free) X. Fewer days in / visits to hospital But busulfan conditioning will still limit adoption. $BEAM may well switch all Casgevy pts but hard to see a dramatic increase in class revenue"  
[X Link](https://x.com/occams_tooth/status/1997348378787655804)  2025-12-06T16:52Z XXX followers, XXX engagements


"Not the key takeaway from the $RNA proxy but I find it hard to believe that the SpinCo Bryce therapeutics has a DCF value of $350M - preclinical programs - economics mostly partnered away - tiny populations (4K US pts) Cant imagine it will fare well on public markets"  
[X Link](https://x.com/occams_tooth/status/1993305334753247722)  2025-11-25T13:06Z XXX followers, XXX engagements


"@seedy19tron $PTGX $APGE"  
[X Link](https://x.com/occams_tooth/status/1996755126900462031)  2025-12-05T01:34Z XXX followers, XXX engagements


"80%+ improvement from first bid to final offer. Incredible compared to biopharma avg in XX (roughly 20%). $RNA $NVS was XX% higher than initial offer even thought there was only one bidder"  
[X Link](https://x.com/occams_tooth/status/1997085041596236120)  2025-12-05T23:25Z XXX followers, XXX engagements


"Interesting that $ARWR benefited from the $WVE INHBE data earlier this week (up roughly $1B in mkt cap) but is not being dragged down by the STAT news article controversy"  
[X Link](https://x.com/occams_tooth/status/1999266267270946931)  2025-12-11T23:53Z XXX followers, 1103 engagements


"$ROIV investor day nice articulation of the switch from short the launch to own the launch Remarkable share price appreciation from post-data/pre-approval to revenue: $ALNY $ARGX $INSM Not in chart but other good examples imo: $BBIO $KRYS $PTCT"  
[X Link](https://x.com/occams_tooth/status/1999560111996481745)  2025-12-12T19:20Z XXX followers, XXX engagements